Comparative evaluation of a laboratory-developed real-time PCR assay and RealStar® Adenovirus PCR Kit for quantitative detection of human adenovirus

Samson S.Y. Wong, Cyril C.Y. Yip, Siddharth Sridhar, Kit Hang Leung, Andrew K.W. Cheng, Ami M.Y. Fung, Ho Yin Lam, Kwok Hung Chan, Jasper F.W. Chan, Vincent C.C. Cheng, Bone S.F. Tang, Kwok Yung Yuen

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Abstract

Background: Human adenoviruses are common causes of community-acquired respiratory tract and enteric infections. Severe disseminated infections with high mortality rates may be seen in immunocompromised individuals. An accurate and cost-effective quantitative assay is essential not only for laboratory diagnosis of adenoviral infections, but also for monitoring of response to antiviral treatment. The diagnostic performance of an in-house quantitative polymerase chain reaction assay was compared to a commercial system. Methods: The analytical sensitivity, specificity, linearity, precision and accuracy of an in-house adenovirus quantitative polymerase chain reaction assay were evaluated against the RealStar® Adenovirus PCR Kit (Altona Diagnostics GmbH, Hamburg, Germany), using 122 clinical specimens and 18 proficiency testing samples. Results: Linear regression analysis of the quantitative results by the in-house assay showed the dynamic range from 2.60 to 9 log10 (plasma) and 2.94 to 9 log10 (viral transport medium) copies/mL, with the coefficient of determination (R2) of 0.996 and 0.998, respectively. A dilution series demonstrated the limits of detection and lower limits of quantification for plasma were 2.06 log10 and 2.60 log10 copies/mL and those for viral transport medium were 2.31 log10 and 2.94 log10 copies/mL respectively. The precision of the in-house assay was highly reproducible among runs with coefficients of variance ranging from 0.07 to 3.21% for plasma and 0.17% to 2.11% for viral transport medium. A comparison of 52 matched samples showed an excellent correlation between the quantitative viral loads measured by the in-house assay and the RealStar® Adenovirus PCR Kit (R2 = 0.984), with an average bias of - 0.16 log10 copies/mL. Conclusions: The in-house adenovirus assay is a sensitive and reliable assay with lower cost for the detection and quantification of adenoviral DNA when compared to the RealStar® Adenovirus PCR Kit.

Original languageEnglish
Article number149
JournalVirology Journal
Volume15
Issue number1
DOIs
Publication statusPublished - Sept 27 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2018 The Author(s).

ASJC Scopus Subject Areas

  • Virology
  • Infectious Diseases

Keywords

  • Human adenovirus
  • Real-time PCR
  • RealStar® Adenovirus PCR Kit

Cite this